nodes	percent_of_prediction	percent_of_DWPC	metapath
Auranofin—PRDX5—oviduct—uterine cancer	0.0717	0.179	CbGeAlD
Auranofin—PRDX5—exocrine gland—uterine cancer	0.0414	0.104	CbGeAlD
Auranofin—PRDX5—myometrium—uterine cancer	0.0229	0.0574	CbGeAlD
Auranofin—PRDX5—epithelium—uterine cancer	0.018	0.0451	CbGeAlD
Auranofin—PRDX5—uterine cervix—uterine cancer	0.0179	0.0447	CbGeAlD
Auranofin—PRDX5—decidua—uterine cancer	0.017	0.0426	CbGeAlD
Auranofin—PRDX5—renal system—uterine cancer	0.0167	0.0418	CbGeAlD
Auranofin—PRDX5—endometrium—uterine cancer	0.0161	0.0404	CbGeAlD
Auranofin—PRDX5—mammalian vulva—uterine cancer	0.0156	0.0391	CbGeAlD
Auranofin—PRDX5—uterus—uterine cancer	0.0149	0.0372	CbGeAlD
Auranofin—IKBKB—myometrium—uterine cancer	0.0136	0.034	CbGeAlD
Auranofin—PRDX5—female reproductive system—uterine cancer	0.0134	0.0335	CbGeAlD
Auranofin—PRDX5—female gonad—uterine cancer	0.0122	0.0305	CbGeAlD
Auranofin—PRDX5—vagina—uterine cancer	0.0121	0.0303	CbGeAlD
Auranofin—Nephrotic syndrome—Medroxyprogesterone Acetate—uterine cancer	0.0117	0.0414	CcSEcCtD
Auranofin—IKBKB—uterine cervix—uterine cancer	0.0106	0.0265	CbGeAlD
Auranofin—IKBKB—smooth muscle tissue—uterine cancer	0.0103	0.0257	CbGeAlD
Auranofin—IKBKB—decidua—uterine cancer	0.0101	0.0252	CbGeAlD
Auranofin—IKBKB—endometrium—uterine cancer	0.00956	0.0239	CbGeAlD
Auranofin—IKBKB—mammalian vulva—uterine cancer	0.00925	0.0232	CbGeAlD
Auranofin—IKBKB—uterus—uterine cancer	0.00881	0.0221	CbGeAlD
Auranofin—IKBKB—female reproductive system—uterine cancer	0.00792	0.0198	CbGeAlD
Auranofin—PRDX5—lymph node—uterine cancer	0.00783	0.0196	CbGeAlD
Auranofin—IKBKB—female gonad—uterine cancer	0.00721	0.018	CbGeAlD
Auranofin—IKBKB—vagina—uterine cancer	0.00716	0.0179	CbGeAlD
Auranofin—Interstitial pneumonia—Etoposide—uterine cancer	0.00661	0.0234	CcSEcCtD
Auranofin—Hepatic enzyme increased—Progesterone—uterine cancer	0.0066	0.0233	CcSEcCtD
Auranofin—Proteinuria—Medroxyprogesterone Acetate—uterine cancer	0.00644	0.0228	CcSEcCtD
Auranofin—Protein urine present—Medroxyprogesterone Acetate—uterine cancer	0.00635	0.0225	CcSEcCtD
Auranofin—IKBKB—lymph node—uterine cancer	0.00463	0.0116	CbGeAlD
Auranofin—Interstitial lung disease—Etoposide—uterine cancer	0.00451	0.016	CcSEcCtD
Auranofin—Aplastic anaemia—Dactinomycin—uterine cancer	0.00415	0.0147	CcSEcCtD
Auranofin—Dysphagia—Progesterone—uterine cancer	0.00392	0.0139	CcSEcCtD
Auranofin—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00355	0.0126	CcSEcCtD
Auranofin—Weight decreased—Progesterone—uterine cancer	0.00355	0.0125	CcSEcCtD
Auranofin—Neuropathy peripheral—Progesterone—uterine cancer	0.00343	0.0121	CcSEcCtD
Auranofin—Jaundice—Progesterone—uterine cancer	0.00341	0.012	CcSEcCtD
Auranofin—Conjunctivitis—Progesterone—uterine cancer	0.0034	0.012	CcSEcCtD
Auranofin—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00321	0.0114	CcSEcCtD
Auranofin—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.0031	0.011	CcSEcCtD
Auranofin—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00309	0.0109	CcSEcCtD
Auranofin—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00309	0.0109	CcSEcCtD
Auranofin—Visual impairment—Progesterone—uterine cancer	0.00302	0.0107	CcSEcCtD
Auranofin—Eye disorder—Progesterone—uterine cancer	0.00293	0.0104	CcSEcCtD
Auranofin—Alopecia—Progesterone—uterine cancer	0.00277	0.0098	CcSEcCtD
Auranofin—Dysphagia—Dactinomycin—uterine cancer	0.00277	0.00979	CcSEcCtD
Auranofin—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.00274	0.00968	CcSEcCtD
Auranofin—ALB—lymph node—uterine cancer	0.00271	0.00677	CbGeAlD
Auranofin—Flatulence—Progesterone—uterine cancer	0.00269	0.00951	CcSEcCtD
Auranofin—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.00266	0.00939	CcSEcCtD
Auranofin—Pancytopenia—Dactinomycin—uterine cancer	0.00263	0.0093	CcSEcCtD
Auranofin—Neutropenia—Dactinomycin—uterine cancer	0.00259	0.00916	CcSEcCtD
Auranofin—Anaemia—Progesterone—uterine cancer	0.00252	0.00892	CcSEcCtD
Auranofin—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00251	0.00888	CcSEcCtD
Auranofin—Angioedema—Progesterone—uterine cancer	0.0025	0.00882	CcSEcCtD
Auranofin—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00244	0.00862	CcSEcCtD
Auranofin—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00242	0.00857	CcSEcCtD
Auranofin—Stomatitis—Dactinomycin—uterine cancer	0.00241	0.00851	CcSEcCtD
Auranofin—Agranulocytosis—Dactinomycin—uterine cancer	0.0023	0.00815	CcSEcCtD
Auranofin—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00229	0.00808	CcSEcCtD
Auranofin—Gingivitis—Epirubicin—uterine cancer	0.00228	0.00807	CcSEcCtD
Auranofin—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00799	CcSEcCtD
Auranofin—Anorexia—Progesterone—uterine cancer	0.00212	0.00751	CcSEcCtD
Auranofin—Gingivitis—Doxorubicin—uterine cancer	0.00211	0.00746	CcSEcCtD
Auranofin—Dysphagia—Etoposide—uterine cancer	0.002	0.00709	CcSEcCtD
Auranofin—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.00699	CcSEcCtD
Auranofin—Dyspepsia—Progesterone—uterine cancer	0.00196	0.00693	CcSEcCtD
Auranofin—Alopecia—Dactinomycin—uterine cancer	0.00196	0.00693	CcSEcCtD
Auranofin—Glossitis—Epirubicin—uterine cancer	0.00194	0.00687	CcSEcCtD
Auranofin—Decreased appetite—Progesterone—uterine cancer	0.00194	0.00685	CcSEcCtD
Auranofin—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00192	0.0068	CcSEcCtD
Auranofin—Constipation—Progesterone—uterine cancer	0.00191	0.00674	CcSEcCtD
Auranofin—Pancytopenia—Etoposide—uterine cancer	0.0019	0.00673	CcSEcCtD
Auranofin—Neutropenia—Etoposide—uterine cancer	0.00187	0.00663	CcSEcCtD
Auranofin—Gastrointestinal pain—Progesterone—uterine cancer	0.00182	0.00644	CcSEcCtD
Auranofin—Glossitis—Doxorubicin—uterine cancer	0.0018	0.00636	CcSEcCtD
Auranofin—Anaemia—Dactinomycin—uterine cancer	0.00178	0.00631	CcSEcCtD
Auranofin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00628	CcSEcCtD
Auranofin—Urticaria—Progesterone—uterine cancer	0.00177	0.00626	CcSEcCtD
Auranofin—Abdominal pain—Progesterone—uterine cancer	0.00176	0.00623	CcSEcCtD
Auranofin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00621	CcSEcCtD
Auranofin—Neuropathy peripheral—Etoposide—uterine cancer	0.00175	0.00619	CcSEcCtD
Auranofin—Melaena—Epirubicin—uterine cancer	0.00175	0.00618	CcSEcCtD
Auranofin—Jaundice—Etoposide—uterine cancer	0.00174	0.00616	CcSEcCtD
Auranofin—Stomatitis—Etoposide—uterine cancer	0.00174	0.00616	CcSEcCtD
Auranofin—Leukopenia—Dactinomycin—uterine cancer	0.00173	0.00611	CcSEcCtD
Auranofin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.0061	CcSEcCtD
Auranofin—Aplastic anaemia—Epirubicin—uterine cancer	0.00168	0.00594	CcSEcCtD
Auranofin—Agranulocytosis—Etoposide—uterine cancer	0.00167	0.0059	CcSEcCtD
Auranofin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00584	CcSEcCtD
Auranofin—Melaena—Doxorubicin—uterine cancer	0.00162	0.00572	CcSEcCtD
Auranofin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00567	CcSEcCtD
Auranofin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.00564	CcSEcCtD
Auranofin—Pruritus—Progesterone—uterine cancer	0.00158	0.00557	CcSEcCtD
Auranofin—Aplastic anaemia—Doxorubicin—uterine cancer	0.00156	0.0055	CcSEcCtD
Auranofin—Thrombocytopenia—Dactinomycin—uterine cancer	0.00154	0.00545	CcSEcCtD
Auranofin—Diarrhoea—Progesterone—uterine cancer	0.00152	0.00539	CcSEcCtD
Auranofin—Anorexia—Dactinomycin—uterine cancer	0.0015	0.00531	CcSEcCtD
Auranofin—Eye disorder—Etoposide—uterine cancer	0.0015	0.0053	CcSEcCtD
Auranofin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00505	CcSEcCtD
Auranofin—Alopecia—Etoposide—uterine cancer	0.00142	0.00501	CcSEcCtD
Auranofin—Vomiting—Progesterone—uterine cancer	0.00142	0.00501	CcSEcCtD
Auranofin—Rash—Progesterone—uterine cancer	0.00141	0.00497	CcSEcCtD
Auranofin—Dermatitis—Progesterone—uterine cancer	0.0014	0.00496	CcSEcCtD
Auranofin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00138	0.00488	CcSEcCtD
Auranofin—Dermatitis exfoliative—Epirubicin—uterine cancer	0.00138	0.00487	CcSEcCtD
Auranofin—Decreased appetite—Dactinomycin—uterine cancer	0.00137	0.00484	CcSEcCtD
Auranofin—Dysgeusia—Etoposide—uterine cancer	0.00137	0.00484	CcSEcCtD
Auranofin—Nausea—Progesterone—uterine cancer	0.00132	0.00468	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.0013	0.0046	CcSEcCtD
Auranofin—Anaemia—Etoposide—uterine cancer	0.00129	0.00456	CcSEcCtD
Auranofin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00129	0.00455	CcSEcCtD
Auranofin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00454	CcSEcCtD
Auranofin—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.00127	0.00451	CcSEcCtD
Auranofin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.0045	CcSEcCtD
Auranofin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.0045	CcSEcCtD
Auranofin—Leukopenia—Etoposide—uterine cancer	0.00125	0.00442	CcSEcCtD
Auranofin—Abdominal pain—Dactinomycin—uterine cancer	0.00125	0.0044	CcSEcCtD
Auranofin—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.0012	0.00425	CcSEcCtD
Auranofin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0012	0.00424	CcSEcCtD
Auranofin—Dysphagia—Epirubicin—uterine cancer	0.00112	0.00397	CcSEcCtD
Auranofin—Thrombocytopenia—Etoposide—uterine cancer	0.00112	0.00395	CcSEcCtD
Auranofin—Eosinophilia—Epirubicin—uterine cancer	0.00111	0.00393	CcSEcCtD
Auranofin—Anorexia—Etoposide—uterine cancer	0.00109	0.00384	CcSEcCtD
Auranofin—Diarrhoea—Dactinomycin—uterine cancer	0.00108	0.00381	CcSEcCtD
Auranofin—Pancytopenia—Epirubicin—uterine cancer	0.00107	0.00377	CcSEcCtD
Auranofin—Neutropenia—Epirubicin—uterine cancer	0.00105	0.00371	CcSEcCtD
Auranofin—Dysphagia—Doxorubicin—uterine cancer	0.00104	0.00368	CcSEcCtD
Auranofin—Eosinophilia—Doxorubicin—uterine cancer	0.00103	0.00364	CcSEcCtD
Auranofin—Weight decreased—Epirubicin—uterine cancer	0.00102	0.00359	CcSEcCtD
Auranofin—Vomiting—Dactinomycin—uterine cancer	0.001	0.00354	CcSEcCtD
Auranofin—Rash—Dactinomycin—uterine cancer	0.000993	0.00351	CcSEcCtD
Auranofin—Decreased appetite—Etoposide—uterine cancer	0.000991	0.0035	CcSEcCtD
Auranofin—Pancytopenia—Doxorubicin—uterine cancer	0.000987	0.00349	CcSEcCtD
Auranofin—Neuropathy peripheral—Epirubicin—uterine cancer	0.000982	0.00347	CcSEcCtD
Auranofin—Stomatitis—Epirubicin—uterine cancer	0.000977	0.00345	CcSEcCtD
Auranofin—Jaundice—Epirubicin—uterine cancer	0.000977	0.00345	CcSEcCtD
Auranofin—Constipation—Etoposide—uterine cancer	0.000975	0.00345	CcSEcCtD
Auranofin—Conjunctivitis—Epirubicin—uterine cancer	0.000974	0.00344	CcSEcCtD
Auranofin—Neutropenia—Doxorubicin—uterine cancer	0.000972	0.00344	CcSEcCtD
Auranofin—Haematuria—Epirubicin—uterine cancer	0.000955	0.00338	CcSEcCtD
Auranofin—Weight decreased—Doxorubicin—uterine cancer	0.000941	0.00333	CcSEcCtD
Auranofin—Nausea—Dactinomycin—uterine cancer	0.000936	0.00331	CcSEcCtD
Auranofin—Agranulocytosis—Epirubicin—uterine cancer	0.000935	0.00331	CcSEcCtD
Auranofin—Gastrointestinal pain—Etoposide—uterine cancer	0.000932	0.0033	CcSEcCtD
Auranofin—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000909	0.00321	CcSEcCtD
Auranofin—Urticaria—Etoposide—uterine cancer	0.000906	0.0032	CcSEcCtD
Auranofin—Jaundice—Doxorubicin—uterine cancer	0.000904	0.00319	CcSEcCtD
Auranofin—Stomatitis—Doxorubicin—uterine cancer	0.000904	0.00319	CcSEcCtD
Auranofin—Abdominal pain—Etoposide—uterine cancer	0.000901	0.00319	CcSEcCtD
Auranofin—Conjunctivitis—Doxorubicin—uterine cancer	0.000901	0.00319	CcSEcCtD
Auranofin—Haematuria—Doxorubicin—uterine cancer	0.000884	0.00312	CcSEcCtD
Auranofin—Visual impairment—Epirubicin—uterine cancer	0.000867	0.00306	CcSEcCtD
Auranofin—Agranulocytosis—Doxorubicin—uterine cancer	0.000865	0.00306	CcSEcCtD
Auranofin—Eye disorder—Epirubicin—uterine cancer	0.000841	0.00297	CcSEcCtD
Auranofin—IKBKB—TNF alpha Signaling Pathway—CCL2—uterine cancer	0.000835	0.00263	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—NRAS—uterine cancer	0.000824	0.00259	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—ERBB2—uterine cancer	0.00082	0.00258	CbGpPWpGaD
Auranofin—IKBKB—IL17 signaling pathway—AKT1—uterine cancer	0.000817	0.00257	CbGpPWpGaD
Auranofin—Pruritus—Etoposide—uterine cancer	0.000807	0.00285	CcSEcCtD
Auranofin—IKBKB—GMCSF-mediated signaling events—HRAS—uterine cancer	0.000803	0.00253	CbGpPWpGaD
Auranofin—Visual impairment—Doxorubicin—uterine cancer	0.000802	0.00284	CcSEcCtD
Auranofin—IKBKB—Downstream TCR signaling—PIK3CA—uterine cancer	0.0008	0.00252	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—CTNNB1—uterine cancer	0.000795	0.0025	CbGpPWpGaD
Auranofin—Alopecia—Epirubicin—uterine cancer	0.000795	0.00281	CcSEcCtD
Auranofin—IKBKB—Insulin Signaling—IGF1R—uterine cancer	0.000794	0.0025	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—uterine cancer	0.000785	0.00247	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—CDKN2A—uterine cancer	0.000783	0.00247	CbGpPWpGaD
Auranofin—Diarrhoea—Etoposide—uterine cancer	0.00078	0.00276	CcSEcCtD
Auranofin—Eye disorder—Doxorubicin—uterine cancer	0.000778	0.00275	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—PTEN—uterine cancer	0.000775	0.00244	CbGpPWpGaD
Auranofin—Flatulence—Epirubicin—uterine cancer	0.000772	0.00273	CcSEcCtD
Auranofin—Dysgeusia—Epirubicin—uterine cancer	0.000767	0.00271	CcSEcCtD
Auranofin—IKBKB—BCR signaling pathway—PTEN—uterine cancer	0.000765	0.00241	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—IRF1—uterine cancer	0.000745	0.00234	CbGpPWpGaD
Auranofin—IKBKB—FAS (CD95) signaling pathway—AKT1—uterine cancer	0.000742	0.00234	CbGpPWpGaD
Auranofin—IKBKB—Cytosolic sensors of pathogen-associated DNA—EP300—uterine cancer	0.000739	0.00233	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—MTHFR—uterine cancer	0.000736	0.00232	CbGpPWpGaD
Auranofin—Alopecia—Doxorubicin—uterine cancer	0.000735	0.0026	CcSEcCtD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—CDKN2A—uterine cancer	0.000735	0.00231	CbGpPWpGaD
Auranofin—Vomiting—Etoposide—uterine cancer	0.000725	0.00256	CcSEcCtD
Auranofin—Anaemia—Epirubicin—uterine cancer	0.000724	0.00256	CcSEcCtD
Auranofin—Rash—Etoposide—uterine cancer	0.000719	0.00254	CcSEcCtD
Auranofin—Dermatitis—Etoposide—uterine cancer	0.000718	0.00254	CcSEcCtD
Auranofin—Flatulence—Doxorubicin—uterine cancer	0.000714	0.00252	CcSEcCtD
Auranofin—Dysgeusia—Doxorubicin—uterine cancer	0.000709	0.00251	CcSEcCtD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—KRAS—uterine cancer	0.000709	0.00223	CbGpPWpGaD
Auranofin—ALB—Vitamin B12 Metabolism—CCL2—uterine cancer	0.000708	0.00223	CbGpPWpGaD
Auranofin—Leukopenia—Epirubicin—uterine cancer	0.000701	0.00248	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—HRAS—uterine cancer	0.000699	0.0022	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—NRAS—uterine cancer	0.000691	0.00218	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—NRAS—uterine cancer	0.000691	0.00218	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—FGFR2—uterine cancer	0.000688	0.00217	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—YWHAE—uterine cancer	0.000684	0.00215	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—NRAS—uterine cancer	0.000683	0.00215	CbGpPWpGaD
Auranofin—Nausea—Etoposide—uterine cancer	0.000677	0.00239	CcSEcCtD
Auranofin—Anaemia—Doxorubicin—uterine cancer	0.00067	0.00237	CcSEcCtD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—FGFR2—uterine cancer	0.000657	0.00207	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—uterine cancer	0.000655	0.00206	CbGpPWpGaD
Auranofin—Leukopenia—Doxorubicin—uterine cancer	0.000649	0.00229	CcSEcCtD
Auranofin—IKBKB—IL-4 Signaling Pathway—PIK3CA—uterine cancer	0.000642	0.00202	CbGpPWpGaD
Auranofin—IKBKB—TWEAK Signaling Pathway—AKT1—uterine cancer	0.000641	0.00202	CbGpPWpGaD
Auranofin—IKBKB—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—EP300—uterine cancer	0.000633	0.00199	CbGpPWpGaD
Auranofin—Thrombocytopenia—Epirubicin—uterine cancer	0.000626	0.00221	CcSEcCtD
Auranofin—IKBKB—Interleukin-11 Signaling Pathway—AKT1—uterine cancer	0.000618	0.00194	CbGpPWpGaD
Auranofin—Anorexia—Epirubicin—uterine cancer	0.000609	0.00215	CcSEcCtD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—CXCL8—uterine cancer	0.000608	0.00192	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—FGFR2—uterine cancer	0.000608	0.00191	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—HRAS—uterine cancer	0.000603	0.0019	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling—PIK3CA—uterine cancer	0.000598	0.00188	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—KRAS—uterine cancer	0.000595	0.00187	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—KRAS—uterine cancer	0.000595	0.00187	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—KRAS—uterine cancer	0.000588	0.00185	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—MTHFR—uterine cancer	0.000585	0.00184	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—PIK3CA—uterine cancer	0.000582	0.00183	CbGpPWpGaD
Auranofin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000579	0.00205	CcSEcCtD
Auranofin—ALB—Folate Metabolism—CCL2—uterine cancer	0.000576	0.00181	CbGpPWpGaD
Auranofin—IKBKB—FoxO family signaling—AKT1—uterine cancer	0.000567	0.00178	CbGpPWpGaD
Auranofin—Anorexia—Doxorubicin—uterine cancer	0.000564	0.00199	CcSEcCtD
Auranofin—Dyspepsia—Epirubicin—uterine cancer	0.000563	0.00199	CcSEcCtD
Auranofin—Decreased appetite—Epirubicin—uterine cancer	0.000556	0.00196	CcSEcCtD
Auranofin—ALB—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000549	0.00173	CbGpPWpGaD
Auranofin—Constipation—Epirubicin—uterine cancer	0.000546	0.00193	CcSEcCtD
Auranofin—IKBKB—Cytokine Signaling in Immune system—SOCS3—uterine cancer	0.000546	0.00172	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—PIK3CA—uterine cancer	0.00054	0.0017	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—PIK3CA—uterine cancer	0.00054	0.0017	CbGpPWpGaD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—HRAS—uterine cancer	0.000539	0.0017	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD8+ T cells—AKT1—uterine cancer	0.000532	0.00168	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—NRAS—uterine cancer	0.00053	0.00167	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—PIK3CA—uterine cancer	0.000527	0.00166	CbGpPWpGaD
Auranofin—IKBKB—IL-4 Signaling Pathway—AKT1—uterine cancer	0.000524	0.00165	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000523	0.00185	CcSEcCtD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—uterine cancer	0.000522	0.00165	CbGpPWpGaD
Auranofin—Dyspepsia—Doxorubicin—uterine cancer	0.00052	0.00184	CcSEcCtD
Auranofin—IKBKB—IL-1 signaling pathway—AKT1—uterine cancer	0.000517	0.00163	CbGpPWpGaD
Auranofin—IKBKB—Cardiac Hypertrophic Response—AKT1—uterine cancer	0.000517	0.00163	CbGpPWpGaD
Auranofin—IKBKB—RANKL/RANK Signaling Pathway—AKT1—uterine cancer	0.000517	0.00163	CbGpPWpGaD
Auranofin—Decreased appetite—Doxorubicin—uterine cancer	0.000514	0.00182	CcSEcCtD
Auranofin—IKBKB—p75(NTR)-mediated signaling—TP53—uterine cancer	0.00051	0.00161	CbGpPWpGaD
Auranofin—Urticaria—Epirubicin—uterine cancer	0.000508	0.00179	CcSEcCtD
Auranofin—IKBKB—mTOR signaling pathway—HRAS—uterine cancer	0.000506	0.00159	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—HRAS—uterine cancer	0.000506	0.00159	CbGpPWpGaD
Auranofin—Constipation—Doxorubicin—uterine cancer	0.000506	0.00179	CcSEcCtD
Auranofin—Abdominal pain—Epirubicin—uterine cancer	0.000505	0.00179	CcSEcCtD
Auranofin—IKBKB—BCR signaling pathway—HRAS—uterine cancer	0.0005	0.00157	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—HRAS—uterine cancer	0.0005	0.00157	CbGpPWpGaD
Auranofin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000484	0.00171	CcSEcCtD
Auranofin—IKBKB—Fc-epsilon receptor I signaling in mast cells—AKT1—uterine cancer	0.000476	0.0015	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL8—uterine cancer	0.000475	0.0015	CbGpPWpGaD
Auranofin—Urticaria—Doxorubicin—uterine cancer	0.00047	0.00166	CcSEcCtD
Auranofin—Abdominal pain—Doxorubicin—uterine cancer	0.000467	0.00165	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—NRAS—uterine cancer	0.000466	0.00147	CbGpPWpGaD
Auranofin—ALB—Selenium Micronutrient Network—CCL2—uterine cancer	0.000458	0.00144	CbGpPWpGaD
Auranofin—IKBKB—Leptin signaling pathway—HRAS—uterine cancer	0.000457	0.00144	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—KRAS—uterine cancer	0.000456	0.00144	CbGpPWpGaD
Auranofin—Pruritus—Epirubicin—uterine cancer	0.000452	0.0016	CcSEcCtD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—uterine cancer	0.000451	0.00142	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—FGFR2—uterine cancer	0.000448	0.00141	CbGpPWpGaD
Auranofin—IKBKB—mTOR signaling pathway—AKT1—uterine cancer	0.000446	0.00141	CbGpPWpGaD
Auranofin—IKBKB—AGE/RAGE pathway—AKT1—uterine cancer	0.000446	0.00141	CbGpPWpGaD
Auranofin—IKBKB—TCR signaling in naïve CD4+ T cells—AKT1—uterine cancer	0.000446	0.00141	CbGpPWpGaD
Auranofin—IKBKB—BCR signaling pathway—AKT1—uterine cancer	0.000441	0.00139	CbGpPWpGaD
Auranofin—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—AKT1—uterine cancer	0.000441	0.00139	CbGpPWpGaD
Auranofin—Diarrhoea—Epirubicin—uterine cancer	0.000437	0.00155	CcSEcCtD
Auranofin—IKBKB—Apoptosis—TP53—uterine cancer	0.000436	0.00137	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—ERBB2—uterine cancer	0.000432	0.00136	CbGpPWpGaD
Auranofin—IKBKB—p75(NTR)-mediated signaling—AKT1—uterine cancer	0.000431	0.00136	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—CTNNB1—uterine cancer	0.000426	0.00134	CbGpPWpGaD
Auranofin—Pruritus—Doxorubicin—uterine cancer	0.000418	0.00148	CcSEcCtD
Auranofin—IKBKB—Innate Immune System—IRF1—uterine cancer	0.000418	0.00131	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—ERBB2—uterine cancer	0.000413	0.0013	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis Modulation and Signaling—TP53—uterine cancer	0.000409	0.00129	CbGpPWpGaD
Auranofin—Vomiting—Epirubicin—uterine cancer	0.000406	0.00144	CcSEcCtD
Auranofin—Diarrhoea—Doxorubicin—uterine cancer	0.000405	0.00143	CcSEcCtD
Auranofin—IKBKB—Leptin signaling pathway—AKT1—uterine cancer	0.000403	0.00127	CbGpPWpGaD
Auranofin—Rash—Epirubicin—uterine cancer	0.000403	0.00142	CcSEcCtD
Auranofin—Dermatitis—Epirubicin—uterine cancer	0.000403	0.00142	CcSEcCtD
Auranofin—IKBKB—Signaling by Interleukins—KRAS—uterine cancer	0.000401	0.00126	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—uterine cancer	0.0004	0.00126	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000397	0.00125	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000397	0.00125	CbGpPWpGaD
Auranofin—IKBKB—TCR Signaling Pathway—HRAS—uterine cancer	0.000395	0.00124	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—HRAS—uterine cancer	0.000388	0.00122	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—PIK3CA—uterine cancer	0.000386	0.00121	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1B—uterine cancer	0.000382	0.0012	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—ERBB2—uterine cancer	0.000382	0.0012	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PTEN—uterine cancer	0.000382	0.0012	CbGpPWpGaD
Auranofin—Nausea—Epirubicin—uterine cancer	0.00038	0.00134	CcSEcCtD
Auranofin—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000378	0.00119	CbGpPWpGaD
Auranofin—Vomiting—Doxorubicin—uterine cancer	0.000376	0.00133	CcSEcCtD
Auranofin—Rash—Doxorubicin—uterine cancer	0.000373	0.00132	CcSEcCtD
Auranofin—Dermatitis—Doxorubicin—uterine cancer	0.000372	0.00132	CcSEcCtD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—HRAS—uterine cancer	0.000372	0.00117	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PTEN—uterine cancer	0.000369	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—PIK3CA—uterine cancer	0.000369	0.00116	CbGpPWpGaD
Auranofin—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—AKT1—uterine cancer	0.000368	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Apoptosis—AKT1—uterine cancer	0.000368	0.00116	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FBXW7—uterine cancer	0.000359	0.00113	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—CDKN1B—uterine cancer	0.000354	0.00111	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PTEN—uterine cancer	0.000352	0.00111	CbGpPWpGaD
Auranofin—Nausea—Doxorubicin—uterine cancer	0.000351	0.00124	CcSEcCtD
Auranofin—IKBKB—TCR Signaling Pathway—AKT1—uterine cancer	0.000348	0.0011	CbGpPWpGaD
Auranofin—IKBKB—TNF alpha Signaling Pathway—AKT1—uterine cancer	0.000342	0.00108	CbGpPWpGaD
Auranofin—IKBKB—Signaling by Interleukins—HRAS—uterine cancer	0.000341	0.00107	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—NRAS—uterine cancer	0.000329	0.00104	CbGpPWpGaD
Auranofin—IKBKB—B Cell Receptor Signaling Pathway—AKT1—uterine cancer	0.000328	0.00103	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—NRAS—uterine cancer	0.000327	0.00103	CbGpPWpGaD
Auranofin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	0.000326	0.00103	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PTEN—uterine cancer	0.000326	0.00103	CbGpPWpGaD
Auranofin—ALB—Platelet degranulation—VEGFA—uterine cancer	0.000317	0.000998	CbGpPWpGaD
Auranofin—IKBKB—Toll-like Receptor Signaling Pathway—AKT1—uterine cancer	0.000315	0.000992	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—NRAS—uterine cancer	0.000314	0.000989	CbGpPWpGaD
Auranofin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	0.000302	0.000951	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—PIK3CA—uterine cancer	0.000301	0.000948	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKR1B10—uterine cancer	0.000301	0.000948	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—SOCS3—uterine cancer	0.000294	0.000926	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000291	0.000918	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—NRAS—uterine cancer	0.000291	0.000915	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—KRAS—uterine cancer	0.000283	0.000891	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—KRAS—uterine cancer	0.000282	0.000887	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—ERBB2—uterine cancer	0.000281	0.000885	CbGpPWpGaD
Auranofin—ALB—Folate Metabolism—TP53—uterine cancer	0.000279	0.00088	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—HRAS—uterine cancer	0.000271	0.000853	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—KRAS—uterine cancer	0.00027	0.000851	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—PIK3CA—uterine cancer	0.000269	0.000847	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—CDKN1B—uterine cancer	0.00026	0.00082	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—uterine cancer	0.00026	0.000819	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—FGFR2—uterine cancer	0.000255	0.000804	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—TP53—uterine cancer	0.00025	0.000788	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—KRAS—uterine cancer	0.00025	0.000787	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—RNF43—uterine cancer	0.000249	0.000785	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—HRAS—uterine cancer	0.000249	0.000784	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—uterine cancer	0.000248	0.000782	CbGpPWpGaD
Auranofin—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—uterine cancer	0.000246	0.000775	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—FGFR2—uterine cancer	0.000245	0.000772	CbGpPWpGaD
Auranofin—ALB—Hemostasis—IRF1—uterine cancer	0.000245	0.000772	CbGpPWpGaD
Auranofin—ALB—Metabolism—NDUFB11—uterine cancer	0.000245	0.00077	CbGpPWpGaD
Auranofin—ALB—Metabolism—SRD5A2—uterine cancer	0.000245	0.00077	CbGpPWpGaD
Auranofin—IKBKB—Immune System—IRF1—uterine cancer	0.000243	0.000766	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—uterine cancer	0.000241	0.000758	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PTEN—uterine cancer	0.00024	0.000755	CbGpPWpGaD
Auranofin—IKBKB—BDNF signaling pathway—AKT1—uterine cancer	0.000239	0.000753	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000238	0.000748	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—PIK3CA—uterine cancer	0.00023	0.000723	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—uterine cancer	0.00023	0.000723	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—INHBA—uterine cancer	0.000228	0.000718	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000224	0.000707	CbGpPWpGaD
Auranofin—IKBKB—Insulin Signaling—AKT1—uterine cancer	0.00022	0.000692	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FBXW7—uterine cancer	0.000218	0.000686	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—NRAS—uterine cancer	0.000218	0.000685	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—NRAS—uterine cancer	0.000214	0.000673	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—HRAS—uterine cancer	0.000213	0.000669	CbGpPWpGaD
Auranofin—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—uterine cancer	0.000212	0.000669	CbGpPWpGaD
Auranofin—IKBKB—MAPK Signaling Pathway—AKT1—uterine cancer	0.000211	0.000666	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKR1C1—uterine cancer	0.000205	0.000647	CbGpPWpGaD
Auranofin—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—uterine cancer	0.000203	0.000639	CbGpPWpGaD
Auranofin—IKBKB—B Cell Activation—AKT1—uterine cancer	0.000188	0.000591	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—KRAS—uterine cancer	0.000187	0.00059	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—KRAS—uterine cancer	0.000184	0.00058	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDH1—uterine cancer	0.000182	0.000575	CbGpPWpGaD
Auranofin—IKBKB—Immune System—SOCS3—uterine cancer	0.000178	0.000562	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKR1B1—uterine cancer	0.000177	0.000557	CbGpPWpGaD
Auranofin—ALB—Metabolism—STAR—uterine cancer	0.000177	0.000557	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000175	0.00055	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—PIK3CA—uterine cancer	0.000172	0.000542	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—PIK3CA—uterine cancer	0.000169	0.000533	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—ERBB2—uterine cancer	0.00016	0.000505	CbGpPWpGaD
Auranofin—IKBKB—Cytokine Signaling in Immune system—HRAS—uterine cancer	0.000159	0.000501	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKR1C3—uterine cancer	0.000158	0.000498	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—HRAS—uterine cancer	0.000156	0.000493	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PGR—uterine cancer	0.000154	0.000485	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—ERBB2—uterine cancer	0.000154	0.000485	CbGpPWpGaD
Auranofin—IKBKB—Immune System—FGFR2—uterine cancer	0.000149	0.000468	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CDKN1B—uterine cancer	0.000148	0.000468	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—YWHAE—uterine cancer	0.000147	0.000463	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—CDKN1B—uterine cancer	0.000143	0.000449	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FBXW7—uterine cancer	0.000141	0.000444	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	0.000141	0.000443	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—CTNNB1—uterine cancer	0.00014	0.000442	CbGpPWpGaD
Auranofin—ALB—Metabolism—POLD1—uterine cancer	0.000139	0.000437	CbGpPWpGaD
Auranofin—IKBKB—Signaling by NGF—AKT1—uterine cancer	0.000138	0.000435	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PTEN—uterine cancer	0.000137	0.000431	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PTEN—uterine cancer	0.000131	0.000413	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—EP300—uterine cancer	0.00013	0.000411	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKR1C1—uterine cancer	0.00013	0.000409	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—STK11—uterine cancer	0.000123	0.000388	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—NRAS—uterine cancer	0.000122	0.000384	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—NRAS—uterine cancer	0.000117	0.000369	CbGpPWpGaD
Auranofin—ALB—Metabolism—RRM2—uterine cancer	0.000116	0.000364	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SOCS3—uterine cancer	0.000115	0.000363	CbGpPWpGaD
Auranofin—ALB—Metabolism—DCN—uterine cancer	0.000112	0.000354	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDH1—uterine cancer	0.000111	0.000349	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN2B—uterine cancer	0.00011	0.000348	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	0.00011	0.000346	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—IGF1R—uterine cancer	0.000107	0.000338	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP11A1—uterine cancer	0.000106	0.000333	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—KRAS—uterine cancer	0.000105	0.000331	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—KRAS—uterine cancer	0.000101	0.000317	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—SMAD3—uterine cancer	0.000101	0.000317	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKR1C3—uterine cancer	9.99e-05	0.000315	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—PIK3CA—uterine cancer	9.65e-05	0.000304	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—FGFR2—uterine cancer	9.61e-05	0.000303	CbGpPWpGaD
Auranofin—IKBKB—Immune System—ERBB2—uterine cancer	9.34e-05	0.000294	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—PIK3CA—uterine cancer	9.26e-05	0.000292	CbGpPWpGaD
Auranofin—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	8.97e-05	0.000283	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—HRAS—uterine cancer	8.92e-05	0.000281	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CDKN1B—uterine cancer	8.65e-05	0.000272	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—HRAS—uterine cancer	8.57e-05	0.00027	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ESR1—uterine cancer	8.23e-05	0.000259	CbGpPWpGaD
Auranofin—IKBKB—Immune System—CTNNB1—uterine cancer	8.17e-05	0.000257	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PTEN—uterine cancer	7.96e-05	0.000251	CbGpPWpGaD
Auranofin—IKBKB—Innate Immune System—AKT1—uterine cancer	7.88e-05	0.000248	CbGpPWpGaD
Auranofin—ALB—Metabolism—STK11—uterine cancer	7.78e-05	0.000245	CbGpPWpGaD
Auranofin—ALB—Metabolism—CYP19A1—uterine cancer	7.78e-05	0.000245	CbGpPWpGaD
Auranofin—ALB—Hemostasis—EP300—uterine cancer	7.65e-05	0.000241	CbGpPWpGaD
Auranofin—IKBKB—Immune System—EP300—uterine cancer	7.59e-05	0.000239	CbGpPWpGaD
Auranofin—IKBKB—Adaptive Immune System—AKT1—uterine cancer	7.57e-05	0.000238	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.31e-05	0.00023	CbGpPWpGaD
Auranofin—ALB—Hemostasis—VEGFA—uterine cancer	7.25e-05	0.000228	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CCL2—uterine cancer	7.24e-05	0.000228	CbGpPWpGaD
Auranofin—ALB—Hemostasis—NRAS—uterine cancer	7.16e-05	0.000225	CbGpPWpGaD
Auranofin—IKBKB—Immune System—NRAS—uterine cancer	7.1e-05	0.000224	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.97e-05	0.000219	CbGpPWpGaD
Auranofin—ALB—Hemostasis—KRAS—uterine cancer	6.16e-05	0.000194	CbGpPWpGaD
Auranofin—IKBKB—Immune System—KRAS—uterine cancer	6.11e-05	0.000193	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—ERBB2—uterine cancer	6.04e-05	0.00019	CbGpPWpGaD
Auranofin—ALB—Metabolism—MTHFR—uterine cancer	5.85e-05	0.000184	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CXCL8—uterine cancer	5.73e-05	0.00018	CbGpPWpGaD
Auranofin—ALB—Hemostasis—PIK3CA—uterine cancer	5.66e-05	0.000178	CbGpPWpGaD
Auranofin—IKBKB—Immune System—PIK3CA—uterine cancer	5.62e-05	0.000177	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CDKN1B—uterine cancer	5.59e-05	0.000176	CbGpPWpGaD
Auranofin—ALB—Hemostasis—TP53—uterine cancer	5.48e-05	0.000172	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—CTNNB1—uterine cancer	5.28e-05	0.000166	CbGpPWpGaD
Auranofin—ALB—Hemostasis—HRAS—uterine cancer	5.24e-05	0.000165	CbGpPWpGaD
Auranofin—IKBKB—Immune System—HRAS—uterine cancer	5.2e-05	0.000164	CbGpPWpGaD
Auranofin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.16e-05	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PTEN—uterine cancer	5.15e-05	0.000162	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—EP300—uterine cancer	4.91e-05	0.000155	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—VEGFA—uterine cancer	4.65e-05	0.000146	CbGpPWpGaD
Auranofin—ALB—Hemostasis—AKT1—uterine cancer	4.63e-05	0.000146	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—NRAS—uterine cancer	4.59e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Immune System—AKT1—uterine cancer	4.59e-05	0.000145	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—KRAS—uterine cancer	3.95e-05	0.000124	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—PIK3CA—uterine cancer	3.63e-05	0.000114	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—TP53—uterine cancer	3.51e-05	0.000111	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—HRAS—uterine cancer	3.36e-05	0.000106	CbGpPWpGaD
Auranofin—ALB—Metabolism—PTEN—uterine cancer	3.25e-05	0.000102	CbGpPWpGaD
Auranofin—ALB—Metabolism—EP300—uterine cancer	3.1e-05	9.77e-05	CbGpPWpGaD
Auranofin—IKBKB—Signaling Pathways—AKT1—uterine cancer	2.97e-05	9.34e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—PIK3CA—uterine cancer	2.3e-05	7.23e-05	CbGpPWpGaD
Auranofin—ALB—Metabolism—AKT1—uterine cancer	1.88e-05	5.91e-05	CbGpPWpGaD
